Cencora, Inc. - SIC # 5048 - OPHTHALMIC GOODS

Ticker Exchange SIC # Website Latest Ticker
COR New York 5048 www.cencora.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cencora, Inc.

Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026? - Oct 6th, 2026 7:30 am
Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026? - Oct 4th, 2026 8:34 am
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release - Oct 2nd, 2026 6:00 am
2 Cash-Producing Stocks with Promising Prospects and 1 We Brush Off - Oct 2nd, 2026 3:42 am
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - Oct 1st, 2026 4:41 pm
1 of Wall Street’s Favorite Stocks with Impressive Fundamentals and 2 We Turn Down - Sep 28th, 2026 7:18 am
AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026? - Sep 25th, 2026 3:22 pm
Cencora Elects Robert E. Sanchez to Its Board of Directors - Sep 25th, 2026 6:00 am
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026? - Sep 24th, 2026 3:19 pm
AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026? - Sep 24th, 2026 2:22 pm
Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery? - Sep 22nd, 2026 7:32 am
Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027 - Sep 21st, 2026 5:02 pm
Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference - Sep 21st, 2026 4:02 am
Cencora (COR) Lifts EPS Outlook And Buyback, Is The Stock Still Below Fair Value? - Sep 20th, 2026 8:08 am
Cencora (COR) Raised Guidance and Bought Back $1B. What’s the Catch? - Sep 19th, 2026 6:38 am
Cencora Tech Chief: AI Is Cutting Some Medical Treatment Decisions in Half - Sep 16th, 2026 1:58 pm
The Realities of Managing Enterprise AI - Sep 15th, 2026 8:29 am
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - Sep 14th, 2026 9:00 am
Coultreon Biopharma Appoints Nate Massari as Chief Business Officer - Sep 14th, 2026 7:00 am
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? - Sep 14th, 2026 5:03 am